Risperidone versus other antipsychotics for people with severe mental illness and co-occurring substance misuse

Background Up to 75% of people with serious mental illness (SMI) such as schizophrenia and bipolar disorder have co‐occurring substance use disorders (dual diagnosis). Dual diagnosis can have an adverse effect on treatment and prognosis of SMI.